NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Maynooth University study reveals how poor sleep impacts Parkinson’s patients

By Irish Pharmacist - 05th Mar 2025

poor sleep impacts Parkinson's patients
iStock.com/Tero Vesalainen

Researchers at Maynooth University’s Kathleen Lonsdale Institute for Human Health Research and Department of Psychology have recently published a study showing that sleep problems are very common in people with Parkinson’s disease, and such sleep problems are associated with poorer quality of life in patients. Parkinson’s disease is the second most common neurodegenerative brain disease after Alzheimer’s, and is estimated to affect 18,000 people in Ireland, and over six million people worldwide.

The MU study, led by PhD candidate Ziba Asadpoordezaki, Research Fellow Dr Beverley Henley, and Professor Andrew Coogan, was published in the Journal of Sleep Research. The research team analysed data from over 38,000 Parkinson’s patients, gathered by the Michael J. Fox Foundation. This comprehensive database includes valuable insights into the patients’ experiences with Parkinson’s, as well as details on their mental health, cognition, and sleep patterns. The findings revealed that an overwhelming 84% of patients with Parkinson’s disease report struggling with sleep issues—significantly higher than the general population of the same age group.

The study highlights the direct consequences of these sleep problems: they were found to be strongly linked to increased symptoms of depression, greater difficulty with independent living, and an overall decline in quality of life. Furthermore, sleep disturbances were found to worsen the severity of ‘OFF periods,’ the times when the effects of Parkinson’s medication diminish, leaving patients vulnerable to a return of debilitating symptoms.

Prof Coogan said: “Sleep problems are a significant burden to quality of life in a number of chronic health conditions. Our study shows how important sleep is to address in Parkinson’s disease, one of the most common and debilitating brain diseases.”

Professor Coogan also noted the key enablers of their research: “The research database from the Michael J. Fox Foundation that we drew on in our study is a great example of the wonderful opportunities presented by large international studies for research that will help advance key questions in human health and benefit patients. In order to best take advantage of such opportunities, we also need collaborations between colleagues, such as facilitated in our study by the Kathleen Lonsdale Institute for Human Health Research at MU, which brings together colleagues with different expertise in health-related research.”

The full study can be found here: https://onlinelibrary.wiley.com/doi/10.1111/jsr.14453

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist February 2025

Welcome to the February 2025 issue of Irish Pharmacist. In this issue, Dr Des Corrigan looks at post-overdose toxic…

Read
erectile dysfunction

Restoring Confidence And Quality Of Life

The days of erectile dysfunction being a taboo subject are gone, and men can now get help without prescription from…

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT